ARTICLE | Product Development
Dealmaking in a pandemic: partnerships speeding COVID-19 countermeasures
COVID-19 makes new and old bedfellows as dealmaking centers on countermeasures
April 4, 2020 3:49 AM UTC
Updated on Apr 6, 2020 at 11:41 PM UTC
COVID-19 may be putting the brakes on a broad swath of biopharma deals, but it has also triggered a host of partnerships for coronavirus countermeasures, pushing vaccine deals to their highest numbers in years. Many of these arrangements knit together actors from across the development spectrum in hopes of a quick and seamless path to market.
Government agencies and non-profits have been stepping up to provide the financial fuel to get these COVID-19 countermeasures off the ground. ...